|
Volumn 290, Issue 5492, 2000, Pages 767-773
|
Neurodegeneration prevented by lentiviral vector delivery of GDNF in primate models of Parkinson's disease
a a a a a a a a a a a a a a a a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
1,2,3,6 TETRAHYDRO 1 METHYL 4 PHENYLPYRIDINE;
GLIAL CELL LINE DERIVED NEUROTROPHIC FACTOR;
VIRUS VECTOR;
ANIMAL CELL;
ANIMAL TISSUE;
ARTICLE;
DRUG DELIVERY SYSTEM;
DRUG EFFICACY;
IMMUNOREACTIVITY;
LENTIVIRINAE;
NERVE CELL DEGENERATION;
NONHUMAN;
PARKINSON DISEASE;
PRIMATE;
PRIORITY JOURNAL;
1-METHYL-4-PHENYL-1,2,3,6-TETRAHYDROPYRIDINE;
AGING;
ANIMALS;
ANTIGENS, CD;
DIHYDROXYPHENYLALANINE;
DISEASE MODELS, ANIMAL;
DOPAMINE;
FEMALE;
GENE EXPRESSION;
GENE THERAPY;
GENETIC VECTORS;
GLIAL CELL LINE-DERIVED NEUROTROPHIC FACTOR;
LENTIVIRUS;
MACACA MULATTA;
NEOSTRIATUM;
NERVE DEGENERATION;
NERVE GROWTH FACTORS;
NERVE TISSUE PROTEINS;
NEURONS;
PARKINSON DISEASE;
PARKINSONIAN DISORDERS;
PSYCHOMOTOR PERFORMANCE;
SUBSTANTIA NIGRA;
TYROSINE 3-MONOOXYGENASE;
|
EID: 0034721690
PISSN: 00368075
EISSN: None
Source Type: Journal
DOI: 10.1126/science.290.5492.767 Document Type: Article |
Times cited : (1182)
|
References (34)
|